• 1923: HUMAN PORTAL BUTYRATE AND PROPIONATE LEVELS ARE ASSOCIATED WITH UNIQUE HEPATIC INNATE IMMUNE GENE PROFILES IN PATIENTS WITH CIRRHOSIS
    Authors: Michael Kriss, MD; Rachael Dran; Elizabeth A Pomfret, MD, PhD; James J Pomposelli, MD, PhD; Trevor Nydam, MD; Crystal Richt, MB (ASCP); Sean Colgan, PhD; Catherine A Lozupone, PhD
    You must log in to access content.
  • 1928: A NOVEL MULTI-OMICS ANALYSIS (VOLARE) REVEALS LIVER-DISEASE SPECIFIC ASSOCIATIONS BETWEEN GUT MICROBIOME, PORTAL METABOLOME, AND HEPATIC GENE EXPRESSION IN HUMANS
    Authors: Michael Kriss, MD; Janet Siebert; Keith Hazleton, MD, PhD; JelenaKlawitter, PhD; Elizabeth A Pomfret, MD, PhD; James J Pomposelli, MD, PhD; Trevor Nydam, MD; Sean Colgan, PhD, Catherine A Lozupone, PhD
    You must log in to access content.
  • 1933: STABLE GUT MICROBIOME COMPOSITION AND DIVERSITY WITH NGM282 THERAPY IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS
    Authors: ArunSanyal, Lei Ling , DuyM. Dinh, Bryan A. Baxter, Alex M. DePaoli, Stephen A. Harrison and RohitLoomba
    You must log in to access content.
  • 1934: PROBIOTICS AMELIORATES PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE THROUGH MODULATION OF GUT-MICROBIOME
    Authors: Na Young Lee, Min Jea Shin, Haripriya Gupta, Ki Tae Suk, Dong Joon Kim, Sang Hak Han
    You must log in to access content.
  • 1950: FEASIBILITY OF DETECTING TRACEABLE ALTERATIONS IN THE BILIARY MICROBIOME USING METAGENOMICS ANALYSES
    Authors: Victoria Gómez, M.D., George Vilanilam, M.D., Irene K. Yan, Tushar C. Patel, M.B., Ch.B, FAASLD
    You must log in to access content.